Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 403 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Normal Weight Clear all

Conditions: Breast Cancer, Obesity
Interventions: Doxorubicin, Cyclophosphamide; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Morbid Obesity
Interventions: Gastrisail; Device
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Ductal Carcinoma In Situ, Breast Cancer
Interventions: Active Comparator: Progressive Resistance Training (PRT) and a healthy diet, Experimental: PRT and a healthy diet, plus weight loss; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Saxagliptin, Placebo; Drug
Lead sponsor: Phoenix VA Health Care System; Federal
Eligibility: 21 Years to 70 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Pain, Back, Obesity, Morbid, Type 2 Diabetes
Interventions: Research electrode; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes Mellitus
Interventions: Metformin, Placebo; Drug
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 10 Years to 20 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Obesity, Insulin Resistance
Interventions: Glucosamine Hydrochloride; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Overweight, Postmenopausal, Breast Cancer
Interventions: weight loss intervention, Weight Loss; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Excessive Weight Gain
Interventions: Niacin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Body Weight, Fat Burn, Cellulite, Abdominal Fat, Adipose Tissue Atrophy
Interventions: Care as Usual Group, Sham Group; Device
Lead sponsor: IR Technology, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Hixson, Tennessee

Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II, Diabetes Mellitus, Adult-Onset, Inflammation
Interventions: Victoza (liraglutide) with dietician monitoring, Placebo with dietician monitoring; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 69 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Herpes Simplex
Interventions: acyclovir sodium; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 120 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Breast Cancer Survivorship, Weight Management, Cardiovascular (CV) Risk, Breast Cancer
Interventions: WeCan-Rural Program; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 5
States / cities: Durham, North Carolina • Henderson, North Carolina • Laurinburg, North Carolina + 2 more

Conditions: Metabolic Syndrome, Obesity
Interventions: High-fat shake; Other
Lead sponsor: Oklahoma State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Breast Cancer, Insomnia, Weight Gain
Interventions: Cognitive-Behavioral Therapy for Insomnia (CBT-I), Sleep Education Control (EDU); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Lutherville, Maryland

Conditions: Obesity, Pharmacokinetics, MRSA, Tuberculosis, PCP
Interventions: Sulfamethoxazole/trimethoprim; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Heart Failure, Diastolic, Obesity
Interventions: Exercise, Dietary Intervention, Diet and exercise, Attention Control; Behavioral · Dietary Supplement · Other
Lead sponsor: Wake Forest University; Other
Eligibility: 60 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Breast Cancer
Interventions: Magnetic Resonance Imaging; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: One-Lung Ventilation, Obesity, Lung Diseases
Interventions: One-lung ventilation with individualized PEEP, One-lung ventilation with low PEEP; Procedure
Lead sponsor: Dionne Peacher; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Obesity, Normal Physiology
Interventions: Room temperatures; Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mitochondrial Diseases, Obesity
Interventions: Tracer-enhanced oral glucose tolerance test (OGTT*), Muscle MRI, Dual energy x-ray absorptiometry (DXA), Questionnaires; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Nutrition and physical activity counseling program; Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Healthy
Interventions: Garlic Oil Macerate; Drug
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Albany, New York

Search by objective public record fields.

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Transmitted Light Tissue Thickness Analysis (TiLTT)

Effects of Diet and Exercise on Ductal Carcinoma in Situ

Beige Fat, Energy, and the Natriuretic Peptide System

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

Brown Adipose Tissue Activation by Spinal Cord Stimulation

Adjunctive Metformin Therapy in Double Diabetes

Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People

Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors

A Study of Niacin Regulation

Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss

Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood

Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia

Weight Management After Cancer for Survivors in Rural Communities

Identification of Early Cardiovascular Disease Risk Factors in Normal-weight Obesity

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations

Exercise Intolerance in Elderly Patients With Diastolic Heart Failure

Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer

Individualized vs Low PEEP in One Lung Ventilation

Energy Expenditure Responses to Different Temperatures

Muscle OXPHOS and Nutrient Homeostasis

Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program

Effect of Garlic on Inflammatory Mediators